SKI Market

Indian Indices

Sensex

81,287.19 -961.42
( -1.17%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

58,843.60 90.21
(0.15%)

Nikkei 225

10,926.32 79.62
(0.73%)

Forex

USD-INR

90.93 0.01
(0.01%)

EUR-INR

107.33 0.10
(0.10%)

GBP-INR

122.97 -0.01
(-0.01%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

40.66

60326.07

EPS(TTM)

Face Value()

Div & Yield %

52.57

0.12

Back

radhagobind commercial ltd

Orient Tradelink standalone net profit declines 27.78% in the September 2025 quarter

Nov 25,2025

Net profit of Orient Tradelink declined 27.78% to Rs 0.39 crore in the quarter ended September 2025 as against Rs 0.54 crore during the previous quarter ended September 2024. Sales declined 3.91% to Rs 2.95 crore in the quarter ended September 2025 as against Rs 3.07 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2.95	3.07	-4
OPM %	-23.05	35.18	-
PBDT	0.70	1.09	-36
PBT	0.52	0.72	-28
NP	0.39	0.54	-28

81,287.19 -961.42 ( -1.17%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

58,843.60 90.21 (0.15%)

10,926.32 79.62 (0.73%)

90.93 0.01 (0.01%)

107.33 0.10 (0.10%)

122.97 -0.01 (-0.01%)

0.58 0.00 (0.12%)